Introduction
First, it needs to be clearly stated that Scottish
Masters Athletics International, NFP, (SMAI), while
not equipped to test athletes at its Masters World
Championships for the use of performance enhancing
drugs (PED), condemns the use of such drugs and has,
in the past, denied records to athletes who have
tested positive in competitions sponsored by other
athletic organizations. However, in light of
established medical knowledge, SMAI has decided to
take a position on the subject of Hormone
Replacement Therapy (HRT) for athletes participating
in its sponsored Masters World Championships. The
position was developed out of the concern for the
health of our athletes and the question of its
inclusion as PED. As an organization devoted to
athletes over the age of 40 years, we are well aware
of the many health concerns affecting our members
and the common issues facing athletes and officials
in all sports. We also are cognizant of the topic of
PED use in sports and the potential for its unfair
advantage in competitions.
Discussion
Low testosterone can have very significant health
risks for an individual, including fatigue,
depression and sleep disturbances, as well as
general well-being. Studies show that it may also
have a role in osteoporosis, cardiovascular disease,
diabetes, various lipid disorders and heart disease.
It is an active area of medical research and new
discoveries have been presented that show age is
related to a drop in free testosterone levels which
predisposes men to a number of unfortunate and
serious health risks.
HRT has shown many of those risks can be averted
and, with treatment, many of the health risks can be
reduced and quality of life restored for patients.
However, with its use comes the very real risk of
abuse. It is
a potent anabolic steroid and studies show it can
have a positive effect on increased muscle size and
strength. The intoxicating effect of rapid fat loss
and muscle gain can lead to misuse and the resulting
unfair advantage in a power sport such as the
Scottish Highland Games.
The adverse effects of low testosterone levels are
apparent and serious and, likewise, the positive
effects of hormone supplementation are significant
and serious. While considering this proposition and
the balance of the issues, it became apparent to
SMAI that the health of the athlete must tip the
scale in favor of allowing the use of HRT under a
doctor’s supervision and judgment while
participating in any competition sponsored by SMAI
is an acceptable risk for us to take.
While we condemn the abuse of any PED and
prohibit the known use of many other PEDs, it would
be against all that we hold valuable to discourage
proper medical therapy.
Conclusion
Therefore, let it be known that SMAI accepts the use
of HRT as a beneficial therapy for the age related
condition commonly called “low testosterone” or the
medical condition of “hypogonadism.” Further, while
acknowledging the very real potential for its abuse,
HRT while under a doctor’s care and judgment is
acceptable while participating in any SMAI sponsored
Masters World Championships. We do not and will not
cause any member to avoid the competition due to the
use of HRT.